(This user asked anonymously)
International Cooperation Officer  |  Thailand

Should we consider different CETs in various situations e.g. rare diseases or end-stage diseases?

Asked: 17 Jan 2024  |   121
Should we consider different CETs in various situations e.g. rare diseases or end-stage diseases?

Leave your reply:

Please sign in before leaving a reply.

Expert Profiles

Yot Teerawattananon

Senior Researcher
Health Intervention and Technology Assessment Program (HITAP)

Dr Abdur Razzaque Sarker

Health Economist
Health Economics and Financing Research, BIDS and Visiting Research Scholar, Health Economics Unit, University of Melbourne, Australia
Please sign in before asking an expert.